Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Stanford University |
---|---|
Information provided by: | Stanford University |
ClinicalTrials.gov Identifier: | NCT00896441 |
The purpose of this study is to help us understand how depression changes brain activity and how this relates to mood, anxiety, and cognitive functions like memory. The investigators also hope to develop a brain imaging test that will predict either before or within two weeks of starting a medicine whether the treatment will work.
Condition | Intervention |
---|---|
Depression Depressive Disorder Mood Disorders |
Drug: Celexa Other: Magnetic Resonance Imaging (MRI) |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Functional MRI Before and After Treatment for Depression |
Estimated Enrollment: | 60 |
Study Start Date: | February 2009 |
Estimated Study Completion Date: | February 2012 |
Estimated Primary Completion Date: | February 2012 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Any contraindication to being scanned in the 3T scanner at the Lucas Center such as having a pacemaker.
or any implanted device that has not been cleared for scanning at 3 Tesla.
Contact: Maureen H Chang, B.S. | 7254620 | mhchang@stanford.edu |
United States, California | |
Stanford University School of Medicine | Recruiting |
Stanford, California, United States, 94305 | |
Contact: Maureen H Chang, B.S. 7254620 mhchang@stanford.edu | |
Contact: Jessica Hawkins, B.S. 7238323 jhawk@stanford.edu | |
Principal Investigator: Michael D Greicius | |
Sub-Investigator: Charles DeBattista | |
Sub-Investigator: Matthew White |
Principal Investigator: | Michael D Greicius | Stanford University |
Responsible Party: | Stanford University School of Medicine ( Michael D Greicius, Principal Investigator ) |
Study ID Numbers: | SU-04202009-2339, 15305 |
Study First Received: | May 7, 2009 |
Last Updated: | May 8, 2009 |
ClinicalTrials.gov Identifier: | NCT00896441 History of Changes |
Health Authority: | United States: Institutional Review Board |
Depression Mental Disorders Mood Disorders Dexetimide |
Depressive Disorder Citalopram Behavioral Symptoms |
Pathologic Processes Disease Depression Mental Disorders |
Mood Disorders Depressive Disorder Behavioral Symptoms |